Previous Article | Next Article ![]()
Infection and Immunity, December 2000, p. 6891-6895, Vol. 68, No. 12
Department of Immunology, Windeyer Institute
of Medical Sciences, University College London, London W1P
6DB,1 and Department of Biochemistry,
Imperial College of Science, Technology and Medicine, London SW7
2AY,2 United Kingdom
Received 6 March 2000/Returned for modification 16 May
2000/Accepted 25 September 2000
Escherichia coli heat-labile enterotoxin (LT) is an
extensively studied adjuvant of mucosal responses. Nevertheless, its
mode of action as an adjuvant remains incompletely understood. In this study, we describe a simplified in vitro model with which to look at
some aspects of immunoregulation by LT. The interaction of LT with the
apical surface of a monolayer of CaCo-2 epithelial cells induces the
release of a soluble factor which inhibits the antigen-induced release
of interleukin-2 by T cells cultured at the basolateral side of the
cells. The release of this factor requires the ADP-ribosylating
activity of LT since the isolated B subunit, as well as an
enzymatically silent LT mutant, loses biological activity in this
model. The inhibitory activity is likely to be due to prostaglandin
release, since it is blocked by indomethacin. The contribution of
LT-induced prostaglandin release to the complex immunoregulatory
activity of LT is discussed.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Inhibition of T-cell Response by Escherichia
coli Heat-Labile Enterotoxin-Treated Epithelial
Cells
*
Corresponding author. Mailing address: Department of
Immunology, Windeyer Institute of Medical Sciences, University College London, 46 Cleveland St., London W1P 6DB, United Kingdom. Phone: 44-20-7679-9402. Fax: 44-20-7679-9357. E-mail:
B.CHAIN{at}UCL.AC.UK.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»